Our results showed that overexpressing TRPC1 increased tau phosphorylation at these sites and elicited cognitive deficits, while pharmacological inhibiting or knockout TRPC1 attenuated these tau phosphorylation sites with improved synaptic and cognitive functions. Here, MAPT is linked to Cognitive impairment.